Zafgen Lands $33,000,000 Series C Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    5 Cambridge Center Floor 2 Cambridge, MA 02142
  • Company Description
    The company is developing novel therapeutics for the treatment of obesity.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be used to support development of Zafgen’s pipeline and to advance its lead methionine aminopeptidase 2 (MetAP2) inhibitor for the treatment of severe obesity into Phase 2 clinical studies.
  • M&A Terms
  • Venture Investor
    Atlas Venture
  • Venture Investor
    Third Rock Ventures

Trending on Xconomy